SA
Highly rated in
3
conditions
Highly rated in
3
conditions
Check Dr. Susan D. Apkon's experience treating your condition:
About Dr. Susan D. Apkon

Susan Apkon is a Physiatrist and a Pediatrics expert in Aurora, Colorado. Apkon has been practicing medicine for over 28 years and is highly rated in 3 conditions, according to our data. Her top areas of expertise are Duchenne Muscular Dystrophy, Dystrophinopathy, Dysferlinopathy, and Spinal Muscular Atrophy SMA. She is licensed to treat patients in Colorado and Washington. Apkon is currently accepting new patients.

Her clinical research consists of co-authoring 42 peer reviewed articles and participating in 6 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Susan D. Apkon it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Susan D. Apkon accepts the following insurance:

  •  Ambetter
  •  Bright Health
  •  Medica
  •  PacificSource
  •  Montana Health Cooperative

Call to see if your plan is accepted.
Locations
13123 E 16th Ave, Aurora, CO 80045
Background & Education
Graduate Institution
University Of Vermont College Of Medicine, 1994
Specialties
Physiatry
Pediatrics
Licenses
Pediatric Rehabilitation Medicine in WA
Hospital Affiliations
Childrens Hospital Colorado - Anschutz Medical Campus
Childrens Hospital Colorado - South Campus Highlands Ranch
Languages Spoken
English
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

An Open-Label, Multi-Center, Study With a Concurrent Untreated Control Arm to Evaluate the Efficacy and Safety of Eteplirsen in Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
View 5 Less Clinical Trials -

42 Total Publications

Respiratory outcomes in children with congenital myotonic dystrophy.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors